← Evidence map

ArticleClinical and translational medicine2020

Proteomic analysis enables distinction of early- versus advanced-stage lung adenocarcinomas.

Olga Kelemen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32536039